190 related articles for article (PubMed ID: 27074145)
1. Maximum-Entropy Models of Sequenced Immune Repertoires Predict Antigen-Antibody Affinity.
Asti L; Uguzzoni G; Marcatili P; Pagnani A
PLoS Comput Biol; 2016 Apr; 12(4):e1004870. PubMed ID: 27074145
[TBL] [Abstract][Full Text] [Related]
2. The Effects of Framework Mutations at the Variable Domain Interface on Antibody Affinity Maturation in an HIV-1 Broadly Neutralizing Antibody Lineage.
Zhou JO; Zaidi HA; Ton T; Fera D
Front Immunol; 2020; 11():1529. PubMed ID: 32765530
[TBL] [Abstract][Full Text] [Related]
3. Predicting HIV-1 broadly neutralizing antibody epitope networks using neutralization titers and a novel computational method.
Evans MC; Phung P; Paquet AC; Parikh A; Petropoulos CJ; Wrin T; Haddad M
BMC Bioinformatics; 2014 Mar; 15():77. PubMed ID: 24646213
[TBL] [Abstract][Full Text] [Related]
4. The challenges of modelling antibody repertoire dynamics in HIV infection.
Luo S; Perelson AS
Philos Trans R Soc Lond B Biol Sci; 2015 Sep; 370(1676):. PubMed ID: 26194760
[TBL] [Abstract][Full Text] [Related]
5. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing.
Wu X; Zhou T; Zhu J; Zhang B; Georgiev I; Wang C; Chen X; Longo NS; Louder M; McKee K; O'Dell S; Perfetto S; Schmidt SD; Shi W; Wu L; Yang Y; Yang ZY; Yang Z; Zhang Z; Bonsignori M; Crump JA; Kapiga SH; Sam NE; Haynes BF; Simek M; Burton DR; Koff WC; Doria-Rose NA; Connors M; ; Mullikin JC; Nabel GJ; Roederer M; Shapiro L; Kwong PD; Mascola JR
Science; 2011 Sep; 333(6049):1593-602. PubMed ID: 21835983
[TBL] [Abstract][Full Text] [Related]
6. Effects of Darwinian Selection and Mutability on Rate of Broadly Neutralizing Antibody Evolution during HIV-1 Infection.
Sheng Z; Schramm CA; Connors M; Morris L; Mascola JR; Kwong PD; Shapiro L
PLoS Comput Biol; 2016 May; 12(5):e1004940. PubMed ID: 27191167
[TBL] [Abstract][Full Text] [Related]
7. Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.
Doria-Rose NA; Schramm CA; Gorman J; Moore PL; Bhiman JN; DeKosky BJ; Ernandes MJ; Georgiev IS; Kim HJ; Pancera M; Staupe RP; Altae-Tran HR; Bailer RT; Crooks ET; Cupo A; Druz A; Garrett NJ; Hoi KH; Kong R; Louder MK; Longo NS; McKee K; Nonyane M; O'Dell S; Roark RS; Rudicell RS; Schmidt SD; Sheward DJ; Soto C; Wibmer CK; Yang Y; Zhang Z; ; Mullikin JC; Binley JM; Sanders RW; Wilson IA; Moore JP; Ward AB; Georgiou G; Williamson C; Abdool Karim SS; Morris L; Kwong PD; Shapiro L; Mascola JR
Nature; 2014 May; 509(7498):55-62. PubMed ID: 24590074
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutation, affinity maturation and the antibody repertoire: a computer model.
Weinand RG
J Theor Biol; 1990 Apr; 143(3):343-82. PubMed ID: 2385109
[TBL] [Abstract][Full Text] [Related]
9. Genetic and structural analyses of affinity maturation in the humoral response to HIV-1.
Kepler TB; Wiehe K
Immunol Rev; 2017 Jan; 275(1):129-144. PubMed ID: 28133793
[TBL] [Abstract][Full Text] [Related]
10. Rhesus Macaque B-Cell Responses to an HIV-1 Trimer Vaccine Revealed by Unbiased Longitudinal Repertoire Analysis.
Dai K; He L; Khan SN; O'Dell S; McKee K; Tran K; Li Y; Sundling C; Morris CD; Mascola JR; Karlsson Hedestam GB; Wyatt RT; Zhu J
mBio; 2015 Nov; 6(6):e01375-15. PubMed ID: 26530382
[TBL] [Abstract][Full Text] [Related]
11. Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation.
Mouquet H; Scheid JF; Zoller MJ; Krogsgaard M; Ott RG; Shukair S; Artyomov MN; Pietzsch J; Connors M; Pereyra F; Walker BD; Ho DD; Wilson PC; Seaman MS; Eisen HN; Chakraborty AK; Hope TJ; Ravetch JV; Wardemann H; Nussenzweig MC
Nature; 2010 Sep; 467(7315):591-5. PubMed ID: 20882016
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of a novel neutralizing antibody targeting the CD4-binding site of HIV-1 gp120.
Qiao Y; Man L; Qiu Z; Yang L; Sun Y; He Y
Antiviral Res; 2016 Aug; 132():252-61. PubMed ID: 27387828
[TBL] [Abstract][Full Text] [Related]
13. CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range.
Yang WP; Green K; Pinz-Sweeney S; Briones AT; Burton DR; Barbas CF
J Mol Biol; 1995 Dec; 254(3):392-403. PubMed ID: 7490758
[TBL] [Abstract][Full Text] [Related]
14. A single mutation turns a non-binding germline-like predecessor of broadly neutralizing antibody into a binding antibody to HIV-1 envelope glycoproteins.
Yuan T; Li J; Zhang MY
MAbs; 2011; 3(4):402-7. PubMed ID: 21540646
[TBL] [Abstract][Full Text] [Related]
15. Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection.
Setliff I; McDonnell WJ; Raju N; Bombardi RG; Murji AA; Scheepers C; Ziki R; Mynhardt C; Shepherd BE; Mamchak AA; Garrett N; Karim SA; Mallal SA; Crowe JE; Morris L; Georgiev IS
Cell Host Microbe; 2018 Jun; 23(6):845-854.e6. PubMed ID: 29861170
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodies.
Kepler TB; Liao HX; Alam SM; Bhaskarabhatla R; Zhang R; Yandava C; Stewart S; Anasti K; Kelsoe G; Parks R; Lloyd KE; Stolarchuk C; Pritchett J; Solomon E; Friberg E; Morris L; Karim SS; Cohen MS; Walter E; Moody MA; Wu X; Altae-Tran HR; Georgiev IS; Kwong PD; Boyd SD; Fire AZ; Mascola JR; Haynes BF
Cell Host Microbe; 2014 Sep; 16(3):304-13. PubMed ID: 25211073
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of PG16 and chimeric dissection with somatically related PG9: structure-function analysis of two quaternary-specific antibodies that effectively neutralize HIV-1.
Pancera M; McLellan JS; Wu X; Zhu J; Changela A; Schmidt SD; Yang Y; Zhou T; Phogat S; Mascola JR; Kwong PD
J Virol; 2010 Aug; 84(16):8098-110. PubMed ID: 20538861
[TBL] [Abstract][Full Text] [Related]
18. Optimal Sequential Immunization Can Focus Antibody Responses against Diversity Loss and Distraction.
Wang S
PLoS Comput Biol; 2017 Jan; 13(1):e1005336. PubMed ID: 28135270
[TBL] [Abstract][Full Text] [Related]
19. An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1.
Bonsignori M; Wiehe K; Grimm SK; Lynch R; Yang G; Kozink DM; Perrin F; Cooper AJ; Hwang KK; Chen X; Liu M; McKee K; Parks RJ; Eudailey J; Wang M; Clowse M; Criscione-Schreiber LG; Moody MA; Ackerman ME; Boyd SD; Gao F; Kelsoe G; Verkoczy L; Tomaras GD; Liao HX; Kepler TB; Montefiori DC; Mascola JR; Haynes BF
J Clin Invest; 2014 Apr; 124(4):1835-43. PubMed ID: 24614107
[TBL] [Abstract][Full Text] [Related]
20. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus.
Liao HX; Lynch R; Zhou T; Gao F; Alam SM; Boyd SD; Fire AZ; Roskin KM; Schramm CA; Zhang Z; Zhu J; Shapiro L; ; Mullikin JC; Gnanakaran S; Hraber P; Wiehe K; Kelsoe G; Yang G; Xia SM; Montefiori DC; Parks R; Lloyd KE; Scearce RM; Soderberg KA; Cohen M; Kamanga G; Louder MK; Tran LM; Chen Y; Cai F; Chen S; Moquin S; Du X; Joyce MG; Srivatsan S; Zhang B; Zheng A; Shaw GM; Hahn BH; Kepler TB; Korber BT; Kwong PD; Mascola JR; Haynes BF
Nature; 2013 Apr; 496(7446):469-76. PubMed ID: 23552890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
